IBRX vs. INBS
IBRX (ImmunityBio, Inc.) and INBS (Intelligent Bio Solutions Inc.) are both stocks. Both are in the Healthcare sector — IBRX in Biotechnology, INBS in Medical Devices. Over the past 5 years, IBRX returned -16.08%/yr vs -79.57%/yr for INBS. At a 0.19 correlation, their price movements are largely independent.
Performance
IBRX vs. INBS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBRX achieves a 268.18% return, which is significantly higher than INBS's -74.19% return.
IBRX
- 1D
- 1.53%
- 1M
- -3.83%
- YTD
- 268.18%
- 6M
- 216.96%
- 1Y
- 148.81%
- 3Y*
- 37.73%
- 5Y*
- -16.08%
- 10Y*
- -0.62%
INBS
- 1D
- 0.82%
- 1M
- 1.65%
- YTD
- -74.19%
- 6M
- -67.06%
- 1Y
- -84.43%
- 3Y*
- -81.20%
- 5Y*
- -79.57%
- 10Y*
- —
IBRX vs. INBS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
IBRX ImmunityBio, Inc. | 268.18% | -22.66% | -49.00% | -0.99% | -16.61% | -54.39% | -24.30% |
INBS Intelligent Bio Solutions Inc. | -74.19% | -31.93% | -65.47% | -91.55% | -86.07% | -80.61% | -32.85% |
Correlation
The correlation between IBRX and INBS is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Dec 24, 2020 | 0.19 |
Fundamentals
IBRX:
$7.49B
INBS:
$3.92M
IBRX:
-$0.89
INBS:
-$11.83
IBRX:
49.79
INBS:
0.62
IBRX:
$140.98M
INBS:
$3.91M
IBRX:
$132.23M
INBS:
$1.26M
IBRX:
-$196.14M
INBS:
-$11.06M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBRX vs. INBS — Risk / Return Rank
IBRX
INBS
IBRX vs. INBS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and Intelligent Bio Solutions Inc. (INBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IBRX | INBS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.90 | ||
| Sortino ratioReturn per unit of downside risk | +3.47 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 0.90 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 3.53 | -0.94 | +4.47 |
| Martin ratioReturn relative to average drawdown | 5.20 | -1.35 | +6.55 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IBRX | INBS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.43 | -0.48 | +1.90 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.14 | -0.37 | +0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.01 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.12 | -0.39 | +0.27 |
Drawdowns
IBRX vs. INBS - Drawdown Comparison
The maximum IBRX drawdown since its inception was -97.14%, roughly equal to the maximum INBS drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for IBRX and INBS.
Loading charts...
Drawdown Indicators
| IBRX | INBS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.14% | -99.99% | +2.85% |
Max Drawdown (1Y)Largest decline over 1 year | -42.44% | -89.82% | +47.38% |
Max Drawdown (3Y)Largest decline over 3 years | -79.34% | -99.46% | +20.12% |
Max Drawdown (5Y)Largest decline over 5 years | -92.83% | -99.98% | +7.15% |
Max Drawdown (10Y)Largest decline over 10 years | -97.03% | — | — |
Current DrawdownCurrent decline from peak | -82.75% | -99.99% | +17.24% |
Average DrawdownAverage peak-to-trough decline | -83.91% | -91.55% | +7.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.74% | 62.44% | -33.70% |
Volatility
IBRX vs. INBS - Volatility Comparison
The current volatility for ImmunityBio, Inc. (IBRX) is 22.30%, while Intelligent Bio Solutions Inc. (INBS) has a volatility of 45.28%. This indicates that IBRX experiences smaller price fluctuations and is considered to be less risky than INBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBRX | INBS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.30% | 45.28% | -22.98% |
Volatility (6M)Calculated over the trailing 6-month period | 88.77% | 129.88% | -41.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 105.21% | 177.57% | -72.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 113.45% | 216.48% | -103.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.38% | 209.33% | -97.95% |
Dividends
IBRX vs. INBS - Dividend Comparison
Neither IBRX nor INBS has paid dividends to shareholders.
Financials
IBRX vs. INBS - Financials Comparison
This section allows you to compare key financial metrics between ImmunityBio, Inc. and Intelligent Bio Solutions Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IBRX and INBS have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INBS has higher volatility (45.28%) compared to IBRX (22.30%). In terms of maximum drawdown, IBRX dropped -97.14% vs INBS's -99.99%.
IBRX currently has the higher Sharpe Ratio (1.43 vs -0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBRX and INBS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer